科軒動力(00476.HK)首輛純電動無障礙公共小巴將在港投入營運
科軒動力(00476.HK)公布,旗下研發及生產的純電動小巴已完成運輸署公共小巴車型審批,即將進行專線小巴路線測試,預期今年底或下年初起投入營運。該車為香港首輛純電動無障礙公共小巴,日前將該車交予專線小巴營運商衍利發展有限公司,以供路線測試。
公司表示,該款純電無障礙小巴專為香港度身訂做,其強大及智能的動力系統,可適應香港複雜路面場境使用,配置高效能磷酸鐵鋰電池,行車時無污染排放,每次充電只需30至60分鐘即能走230公里。車長7米,行走靈活而且車內空間寬敞,低地台設計,方便殘疾人士及長者乘坐。(gc/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.